Literature DB >> 17089179

Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen.

Aurélien Descazeaud1, Mark Rubin, Stéphanie Chemama, Stéphane Larré, Laurent Salomon, Yves Allory, Dimitri Vordos, Andras Hoznek, René Yiou, Dominique Chopin, Claude Abbou, Alexandre de la Taille.   

Abstract

A 21-samples saturation biopsy procedure (SBP) was developed in order to improve prostate cancer detection rate. Out of 650 patients who underwent this protocol, 150 had a clinically localized prostate cancer and underwent a radical prostatectomy. The number of cores positive for tumor was assessed in the SBP, and also in the sextant component of the SBP (SC) and in the non-sextant component of the SBP (NSC). Numbers of cores positive for tumor on SBP, SC, and NSC were significantly higher in pT3 group versus pT2 (P < 0.001 each) and in positive surgical margins (PSM) group versus no PSM (P < 0.001 each). When comparing area under the curve obtained from SBP with those obtained from NSC and SC, the SBP showed higher accuracy than the NSC and the SC for the prediction of pT3 and PSM. On multivariate analyses, SC and NSC were independent predictors of pT3 and PSM on radical prostatectomy.

Entities:  

Mesh:

Year:  2006        PMID: 17089179     DOI: 10.1007/s00345-006-0134-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   3.661


  17 in total

1.  Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Authors:  A W Partin; P C Walsh
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

Review 2.  Making the most out of six systematic sextant biopsies.

Authors:  T A Stamey
Journal:  Urology       Date:  1995-01       Impact factor: 2.649

3.  Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy.

Authors:  L Cheng; J Slezak; E J Bergstralh; R P Myers; H Zincke; D G Bostwick
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

4.  A catalog of prostate cancer nomograms.

Authors:  P L Ross; P T Scardino; M W Kattan
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

5.  Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.

Authors:  Makoto Ohori; Michael W Kattan; Hideshige Koh; Norio Maru; Kevin M Slawin; Shahrokh Shariat; Masatoshi Muramoto; Victor E Reuter; Thomas M Wheeler; Peter T Scardino
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

6.  Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.

Authors:  D A Ackerman; J M Barry; R A Wicklund; N Olson; B A Lowe
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

7.  A comparison of extended biopsy and sextant biopsy schemes for predicting the pathological stage of prostate cancer.

Authors:  Yoshio Naya; Atsushi Ochiai; Patricia Troncoso; R Joseph Babaian
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

8.  The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Authors:  Yair Lotan; Shahrokh F Shariat; Seyed M Khoddami; Hossein Saboorian; Kenneth S Koeneman; Jeffrey A Cadeddu; Arthur I Sagalowsky; John D McConnell; Claus G Roehrborn
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

9.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Authors:  K K Hodge; J E McNeal; M K Terris; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

10.  Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.

Authors:  P A Peller; D C Young; D P Marmaduke; W L Marsh; R A Badalament
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

View more
  8 in total

Review 1.  [MRI/TRUS fusion-guided prostate biopsy : Value in the context of focal therapy].

Authors:  T Franz; J von Hardenberg; A Blana; H Cash; D Baumunk; G Salomon; B Hadaschik; T Henkel; J Herrmann; F Kahmann; K-U Köhrmann; J Köllermann; S Kruck; U-B Liehr; S Machtens; I Peters; J P Radtke; A Roosen; H-P Schlemmer; L Sentker; J J Wendler; U Witzsch; J-U Stolzenburg; M Schostak; R Ganzer
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

Review 2.  [Prostate gland - what would urologists like to know from radiologists?]

Authors:  U B Liehr; D Baumunk; S Blaschke; F Fischbach; B Friebe; F König; A Lemke; P Mittelstädt; M Pech; M Porsch; J Ricke; D Schindele; S Siedentopf; J J Wendler; M Schostak
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

3.  Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.

Authors:  Idir Ouzaid; Evanguelos Xylinas; Alexandre Campeggi; Andras Hoznek; Dimitri Vordos; Claude-Clément Abbou; Francis Vacherot; Laurent Salomon; Alexandre de la Taille; Guillaume Ploussard
Journal:  World J Urol       Date:  2011-11-25       Impact factor: 4.226

4.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.

Authors:  Peter A Pinto; Paul H Chung; Ardeshir R Rastinehad; Angelo A Baccala; Jochen Kruecker; Compton J Benjamin; Sheng Xu; Pingkun Yan; Samuel Kadoury; Celene Chua; Julia K Locklin; Baris Turkbey; Joanna H Shih; Stacey P Gates; Carey Buckner; Gennady Bratslavsky; W Marston Linehan; Neil D Glossop; Peter L Choyke; Bradford J Wood
Journal:  J Urol       Date:  2011-08-17       Impact factor: 7.450

Review 5.  Saturation biopsies for prostate cancer: current uses and future prospects.

Authors:  Nicolas B Delongchamps; Gabriel P Haas
Journal:  Nat Rev Urol       Date:  2009-11-10       Impact factor: 14.432

6.  Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer.

Authors:  Nicolas B Delongchamps; Gustavo de la Roza; Richard Jones; Mary Jumbelic; Gabriel P Haas
Journal:  BJU Int       Date:  2008-08-01       Impact factor: 5.588

7.  Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study.

Authors:  Yuji Watanabe; Akito Terai; Tohru Araki; Masako Nagayama; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Mana Ishibashi; Satoru Nakashita; Yoshihiro Dodo
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

8.  Beyond diagnosis: evolving prostate biopsy in the era of focal therapy.

Authors:  J L Dominguez-Escrig; S R C McCracken; D Greene
Journal:  Prostate Cancer       Date:  2010-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.